Studies have previously demonstrated that the enhancer of zeste homolog 2 (EZH2) plays a regulatory role in Lipid Metabolism, and simultaneous targeting of EZH2 and Fatty Acid Synthesis results in cancer cell death (46). The gene discussed is EZH2; the disease is cancer.